Winton Group LTD Intercept Pharmaceuticals, Inc. Transaction History

Winton Group LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$12.53 - $21.71 $23,769 - $41,183	1,897 Added 9.15%	22,620 $303,000
Q4 2022 Feb 14, 2023	BUY	$11.61 - $16.11 $10,274 - $14,257	885 Added 4.46%	20,723 $256,000
Q3 2022 Nov 10, 2022	SELL	$12.21 - $19.7 $29,572 - $47,713	-2,422 Reduced 10.88%	19,838 $277,000
Q2 2022 Aug 10, 2022	BUY	$11.23 - $19.59 $55,027 - $95,991	4,900 Added 28.23%	22,260 $307,000
Q1 2022 May 11, 2022	BUY	$13.37 - $17.79 $46,607 - $62,015	3,486 Added 25.13%	17,360 $282,000
Q4 2021 Feb 10, 2022	BUY	$14.28 - $19.53 $198,120 - $270,959	13,874 New	13,874 $226,000
Q3 2021 Oct 28, 2021	SELL	$12.99 - $20.47 $203,475 - $320,642	-15,664 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$15.46 - $24.5 $47,941 - $75,974	3,101 Added 24.68%	15,664 $313,000
Q1 2021 Jul 21, 2021	BUY	$19.33 - $37.75 $242,842 - $474,253	12,563 New	12,563 $290,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.